Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norman Rosenthal

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
The American Journal of Psychiatry|April 5, 2014
Effect of an acute intranasal aerosol dose of PH94B on social and performance anxiety in women with social anxiety disorderMichael R Liebowitz, Ester Salman, Humberto Nicolini, et al.
Circulation|November 15, 2017
Cardiovascular Outcomes and Risks After Initiation of a Sodium Glucose Cotransporter 2 Inhibitor: Results From the EASEL Population-Based Cohort Study (Evidence for Cardiovascular Outcomes With Sodium Glucose Cotransporter 2 Inhibitors in the Real World)Jacob A Udell, Zhong Yuan, Toni Rush, et al.
American Journal of Surgery|March 26, 2004
Combination tramadol plus acetaminophen for postsurgical painAdam B Smith, Thanjavur S Ravikumar, Marc Kamin, et al.
Endocrinology, Diabetes & Metabolism|January 11, 2020
Cardiovascular outcomes and mortality after initiation of canagliflozin: Analyses from the EASEL StudyJacob A Udell, Zhong Yuan, Patrick Ryan, et al.
Diabetes, Obesity & Metabolism|June 26, 2018
Comparative effectiveness of canagliflozin, SGLT2 inhibitors and non-SGLT2 inhibitors on the risk of hospitalization for heart failure and amputation in patients with type 2 diabetes mellitus: A real-world meta-analysis of 4 observational databases (OBSERVE-4D)Patrick B Ryan, John B Buse, Martijn J Schuemie, et al.
Diabetes Care|November 7, 2020
Insulin-Like Growth Factor Binding Protein 7 Predicts Renal and Cardiovascular Outcomes in the Canagliflozin Cardiovascular Assessment StudyJames L Januzzi, Javed Butler, Naveed Sattar, et al.
Journal of the American College of Cardiology|February 4, 2022
Stress Cardiac Biomarkers, Cardiovascular and Renal Outcomes, and Response to CanagliflozinMuthiah Vaduganathan, Naveed Sattar, Jialin Xu, et al.
The American Journal of Psychiatry|December 8, 2006
Binge eating disorder: a stable syndromeHarrison G Pope, Justine K Lalonde, Lindsay J Pindyck, et al.
American Journal of Nephrology|January 11, 2022
Clinical Utility of KidneyIntelX in Early Stages of Diabetic Kidney Disease in the CANVAS TrialDavid Lam, Girish N Nadkarni, Gohar Mosoyan, et al.
Diabetes Care|June 20, 2022
Fasting Substrate Concentrations Predict Cardiovascular Outcomes in the CANagliflozin cardioVascular Assessment Study (CANVAS)Ele Ferrannini, Simona Baldi, Tiziana Scozzaro, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
The American Journal of Psychiatry|April 5, 2014
Effect of an acute intranasal aerosol dose of PH94B on social and performance anxiety in women with social anxiety disorderMichael R Liebowitz, Ester Salman, Humberto Nicolini, et al.
Circulation|November 15, 2017
Cardiovascular Outcomes and Risks After Initiation of a Sodium Glucose Cotransporter 2 Inhibitor: Results From the EASEL Population-Based Cohort Study (Evidence for Cardiovascular Outcomes With Sodium Glucose Cotransporter 2 Inhibitors in the Real World)Jacob A Udell, Zhong Yuan, Toni Rush, et al.
American Journal of Surgery|March 26, 2004
Combination tramadol plus acetaminophen for postsurgical painAdam B Smith, Thanjavur S Ravikumar, Marc Kamin, et al.
Endocrinology, Diabetes & Metabolism|January 11, 2020
Cardiovascular outcomes and mortality after initiation of canagliflozin: Analyses from the EASEL StudyJacob A Udell, Zhong Yuan, Patrick Ryan, et al.
Diabetes, Obesity & Metabolism|June 26, 2018
Comparative effectiveness of canagliflozin, SGLT2 inhibitors and non-SGLT2 inhibitors on the risk of hospitalization for heart failure and amputation in patients with type 2 diabetes mellitus: A real-world meta-analysis of 4 observational databases (OBSERVE-4D)Patrick B Ryan, John B Buse, Martijn J Schuemie, et al.
Diabetes Care|November 7, 2020
Insulin-Like Growth Factor Binding Protein 7 Predicts Renal and Cardiovascular Outcomes in the Canagliflozin Cardiovascular Assessment StudyJames L Januzzi, Javed Butler, Naveed Sattar, et al.
Journal of the American College of Cardiology|February 4, 2022
Stress Cardiac Biomarkers, Cardiovascular and Renal Outcomes, and Response to CanagliflozinMuthiah Vaduganathan, Naveed Sattar, Jialin Xu, et al.
The American Journal of Psychiatry|December 8, 2006
Binge eating disorder: a stable syndromeHarrison G Pope, Justine K Lalonde, Lindsay J Pindyck, et al.
American Journal of Nephrology|January 11, 2022
Clinical Utility of KidneyIntelX in Early Stages of Diabetic Kidney Disease in the CANVAS TrialDavid Lam, Girish N Nadkarni, Gohar Mosoyan, et al.
Diabetes Care|June 20, 2022
Fasting Substrate Concentrations Predict Cardiovascular Outcomes in the CANagliflozin cardioVascular Assessment Study (CANVAS)Ele Ferrannini, Simona Baldi, Tiziana Scozzaro, et al.
Pageof 4